Medibio Ltd
ASX:MEB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kleos Space SA
ASX:KSS
|
LU |
|
Suchitra Finance & Trading Co Ltd
BSE:538714
|
IN |
|
K
|
Kao Corp
XBER:KAO
|
JP |
|
J
|
Jiangxi Sunshine Dairy Co Ltd
SZSE:001318
|
CN |
Medibio Ltd
Research & Development
Medibio Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Medibio Ltd
ASX:MEB
|
Research & Development
-AU$307.2k
|
CAGR 3-Years
5%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Research & Development
-AU$568.2k
|
CAGR 3-Years
54%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medibio Ltd
Glance View
Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.
See Also
What is Medibio Ltd's Research & Development?
Research & Development
-307.2k
AUD
Based on the financial report for Jun 30, 2023, Medibio Ltd's Research & Development amounts to -307.2k AUD.
What is Medibio Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
38%
Over the last year, the Research & Development growth was 62%. The average annual Research & Development growth rates for Medibio Ltd have been 5% over the past three years , 38% over the past five years .